Pain
From the Journals
NSAIDs don’t make COVID-19 worse in hospitalized patients
In a British study, hospitalized patients didn’t fare worse if they’d taken NSAIDs regularly before admission.
Conference Coverage
Hypertension worsened by commonly used prescription meds
Close to 20% of U.S. adults with hypertension are on a prescription drug, such as NSAIDs, known to raise blood pressure, creating an opportunity...
From the Journals
High variability found in studies assessing hemophilia-related pain
News
FDA OKs higher-dose naloxone nasal spray for opioid overdose
Kloxxado delivers 8 mg of naloxone into the nasal cavity, which is twice as much as the 4 mg of naloxone contained in Narcan.
From the Journals
Doctors more likely to prescribe opioids to COVID ‘long-haulers,’ raising addiction fears
The new study “suggests to me that many clinicians still don’t get it,” said Dr. Andrew Kolodny.
News from the FDA/CDC
FDA warning letters target OTC cannabidiol product claims for pain relief
The FDA sent warning letters to two manufacturers for illegal marketing of drugs containing cannabidiol (CBD) and a failure to comply with current...
Conference Coverage
Joint pain in patients with hemophilia may be neuropathic
From the Journals
How to convince patients muscle pain isn’t a statin Achilles heel: StatinWISE
The strategy seemed to work in this trial: two-thirds of patients who previously rejected statins, perceiving them as the cause of muscle pain,...
Feature
Women increasingly turn to CBD, with or without doc’s blessing
Women of reproductive age are increasingly turning to cannabinoids to treat gynecologic and other conditions. A study shows they’re not waiting...
From the Journals
Opioid-related deaths lower in counties with active cannabis dispensaries
Evidence of a negative association between legalization of medical or recreational cannabis and opioid-related mortality has been mixed.
Feature
Tough pain relief choices in the COVID-19 pandemic